JG
CELL

Jefferies Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Jefferies Group’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-34,000
Closed -$1.52M – 2100
2021
Q2 		$1.52M Buy
+34,000
New +$1.58M 0.01% 845

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Jefferies Group's CELL Position: Q1 2021 in Review

Jefferies Group sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2021, closing a stake of 7,700 shares — an estimated $688K sold.

Jefferies Group first reported a position in CELL in Q4 2020 and held it in 1 quarter. The position peaked at $688K in Q4 2020. 155 funds tracked by Wall St. Rank hold CELL as of Q1 2021.

  • Jefferies Group reported no remaining PhenomeX Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Jefferies Group sold 7,700 PhenomeX Inc. Common Stock shares in Q1 2021, an estimated $688K.
  • Jefferies Group first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Jefferies Group's PhenomeX Inc. Common Stock position peaked at $688K in Q4 2020.
  • 155 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2021.

Based on Jefferies Group's 13F filing for Q1 2021, filed 14 May 2021.